New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Shineco, Inc.
SISI
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

8M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

8M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

0.23USD
Shape-0.03 ( -11.03%)
favorite-chart

Relative Strenght

80
favorite-chart

Volume Buzz

13%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

95%

Quote Panel

Shape
Updated October 4, 2024
1W -5.01 % 1M -49.88 % 3M -93.08 % 1Y -83.63 %

Key Metrics

Shape
  • Market Cap

    7.91M


  • Shares Outstanding

    33.82M


  • Share in Float

    30.01M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    0.234


  • Average Volume

    2.28M


  • Beta

    -0.04


  • Range

    0.198-4.902


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.biosisi.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.94x

P/S Ratio

0.04x

P/B Ratio

0.8

Debt/Equity

-359.2%

Net Margin

$-3.8

EPS

How SISI compares to sector?

P/E Ratio

Relative Strength

Shape

SISI

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1M

Shape-18%

2024-Revenue

$673K

Shape64%

2024-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

N/A

-3.20
vs -4.09

Q1.22

arrow
arrow

N/A

-3.00
vs -2.36

Q2.22

arrow
arrow

N/A

-0.65
vs -1.32

Q3.22

arrow
arrow

N/A

-1.70
vs -13.30

Q4.22

arrow
arrow

N/A

-1.60
vs -3.20

Q1.23

arrow
arrow

N/A

-1.30
vs -3.00

Q2.23

arrow
arrow

N/A

-0.24
vs -0.65

Q3.23

arrow
arrow

N/A

-1.10
vs -1.70

Q4.23

arrow
arrow

N/A

-8.40
vs -1.60

Q1.24

arrow
arrow

N/A

-0.52
vs -1.30

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

-76%

732.6K  vs 3.1M

Q1.22

arrow
arrow

-69%

618.1K  vs 2M

Q2.22

arrow
arrow

+103%

206K  vs -6175397

Q3.22

arrow
arrow

-15%

535.7K  vs 629.8K

Q4.22

arrow
arrow

-26%

539.2K  vs 732.6K

Q1.23

arrow
arrow

+12%

693K  vs 618.1K

Q2.23

arrow
arrow

-691%

-1217501.00  vs 206K

Q3.23

arrow
arrow

+207%

1.6M  vs 535.7K

Q4.23

arrow
arrow

+328%

2.3M  vs 539.2K

Q1.24

arrow
arrow

+95%

1.3M  vs 693K

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

+28%

0.28
vs -0.07

Q3.22

arrow
arrow

-6%

-0.06
vs 0.28

Q4.22

arrow
arrow

-5%

-0.05
vs -0.06

Q1.23

arrow
arrow

-7%

-0.07
vs -0.05

Q2.23

arrow
arrow

-11%

-0.11
vs -0.07

Q3.23

arrow
arrow

-9%

-0.09
vs -0.11

Q4.23

arrow
arrow

-11%

-0.11
vs -0.09

Q1.24

arrow
arrow

-9%

-0.09
vs -0.11

Institutionnal OwnershipShape

status-upQoQ

Q1.22

arrow
arrow

4

4
vs 3

33%

Q2.22

arrow
arrow

3

3
vs 4

-25%

Q3.22

arrow
arrow

3

3
vs 3

NA

Q4.22

arrow
arrow

3

3
vs 3

NA

Q1.23

arrow
arrow

3

3
vs 3

NA

Q2.23

arrow
arrow

3

3
vs 3

NA

Q3.23

arrow
arrow

6

6
vs 3

100%

Q4.23

arrow
arrow

4

4
vs 6

-33%

Earnings Growth

Latest News